Ruofan Liu

机构：Anhui University, University of Washington, Southern Medical University, The University of Texas at Austin · ORCID：0009-0007-9880-0290

发表论文 30 篇 · 总被引 463 次 · h-index 13

代表论文

• Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis (2023 · Molecular Therapy · 被引 80)
• Gut commensal metabolite rhamnose promotes macrophages phagocytosis by activating SLC12A4 and protects against sepsis in mice (2024 · Acta Pharmaceutica Sinica B · 被引 38)
• A metabolite from commensal Candida albicans enhances the bactericidal activity of macrophages and protects against sepsis (2023 · Cellular and Molecular Immunology · 被引 33)
• Functionalization of Gold-Pincer Nanocluster for Asymmetric Catalysis (2025 · Journal of the American Chemical Society · 被引 23)
• An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1 (2023 · Journal of Hepatology · 被引 21)
• Preparation of Vanillin-Taurine Antioxidant Compound, Characterization, and Evaluation for Improving the Post-Harvest Quality of Litchi (2023 · Antioxidants · 被引 21)